Animal Clinical Investigation

Animal Clinical Investigation (ACI) is a company based in Chevy Chase, Maryland, with a team of 30 employees. Established nearly 20 years ago, ACI specializes in connecting the demand for expertise in new animal drug development with a network of specialized professionals. ACI offers a comprehensive suite of services for pharmaceutical and biotechnology companies seeking to develop novel treatments for pets. Their expertise spans multiple areas, including Chemistry, Manufacturing and Controls (CMC), Target Animal Safety (TAS), Target Animal Effectiveness (TAE), and Regulatory Affairs. ACI assists companies in navigating the complexities of regulatory bodies such as the Center for Veterinary Medicine (CVM), USDA-Center for Veterinary Biologics, Health Canada’s Veterinary Drugs Directorate (VDD), the Japanese Ministry of Agriculture, Forestry and Fisheries, the European Medicines Agency (EMA), and the Ministério da Agricultura, Pecuária e Abastecimento (MAPA) in Brazil. ACI distinguishes itself through its collaborative approach, working closely with sponsors to provide timely access to subject matter experts and build dedicated new product development teams. Their team possesses extensive experience gained from veterinary practices, universities, animal health companies, and human health companies, as well as the CVM. ACI supports the entire development process, from protocol writing and biostatistical planning to regulatory submissions. For inquiries or to explore partnership opportunities, you can visit Animal Clinical Investigation's website at animalci.com.